Should we give up on anti-B-cell antibody therapy in the treatment of lupus nephritis?
For those of us managing patients with active lupus nephritis, the promise of a safe new therapy five years ago – anti-CD20 monoclonal antibody therapy against B cells- seemed like a breath of fresh air. A number of…